A publicly listed company on the New York Stock Exchange recently made a big move that left many people stunned.

Pineapple Financial has allocated 100 million USD to establish a digital asset reserve pool, fully betting on INJ. This is not a trial, nor is it a small allocation for the sake of appearance, but a substantial investment of real money, and they have publicly stated their intention to continue buying in the secondary market.

This nature has changed.

In the past, institutions bought coins with some degree of "allocating positions to diversify risks" in mind. But this time it's completely different – a traditional financial institution is treating the native asset of a certain Layer 1 public chain as a strategic reserve asset. There is no second case like this in the entire history of the cryptocurrency industry.

The more hardcore aspect is that they do not intend to just buy and hold passively, but will continue to increase their positions based on market conditions. In other words, every time the price of INJ experiences a pullback, there is a "national team" certified by the New York Stock Exchange stepping in to absorb the chips.

This is equivalent to giving this token a perpetual buying engine.

On a deeper level, this matter conveys a signal: some traditional financial institutions have begun to view projects like Injective as key nodes connecting the traditional market with the on-chain world. When a company's quarterly financial report seriously states "holding INJ assets worth $100 million," the positioning of INJ has fundamentally shifted—from a mere speculative target to a reserve asset backed by institutional endorsement.

The market structure is quietly being restructured.